纵横研报
Ticker Detail

603387.SHG

¥9.23+10.01% 基蛋生物 Medical Devices
00Reports China 医疗健康
Getein Biotech Inc
医疗健康 · 医疗器械

Getein Biotech, Inc researches, develops, produces, and sells in vitro diagnostic reagents and instruments in China and internationally. The company provides point-of-care detection, chemiluminescence detection, biochemical analysis, molecular testing, thrombus and hemostasis detection, blood cell analysis detection, urine analysis, quality control products, diagnostic raw materials, biochemical immunity, and other fields, such as myocardium, inflammation, renal function, thyroid function, hormones, glucose metabolism, tumor, coagulation, blood cells detection. The company was founded in 2002 and is headquartered in Nanjing, China.

MARKET 市值 4.17B CNY PE 17.9x 52W ¥7.37 – ¥11.42 EODHD · Q 2026-03-31 · 同步 2026-07-12
QUALITY PEG 营收 YoY 9.6% ROE 7.8% 营业利润率 28.2% 净利润率 21.6%
ANALYST 股息率 2.96%

暂无相关研报

数据库中已收录该标的的基本面数据,可发起一份定制研报。

CUSTOM RESEARCH · 定制研报 没找到完全契合的标的?让我们替你做一份。 告诉我们你关心的标的与偏好,1 个工作日内在站内上线。 开始定制